Innate Pharma SA
NASDAQ:IPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innate Pharma SA
NASDAQ:IPHA
|
FR |
|
Relicab Cable Manufacturing Ltd
BSE:539760
|
IN |
|
Athabasca Oil Corp
F:ATI
|
CA |
|
Yesco Holdings Co Ltd
KRX:015360
|
KR |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Cathedra Bitcoin Inc
OTC:CBTTF
|
CA |
|
D
|
Diana Shipping Inc
XBER:DSZ
|
GR |
|
Alpha Star Acquisition Corp
OTC:ALSAF
|
US |
|
C
|
Cantor Equity Partners VI Inc
NASDAQ:CEPS
|
US |
|
Sparebank 1 SMN
F:SJI
|
NO |
|
O
|
Orient Beverages Ltd
BSE:507690
|
IN |
|
D
|
Deluxe Corp
SWB:DL8
|
US |
|
T
|
Toyota Motor Corp
XMUN:TOM
|
JP |
|
N
|
Northview Acquisition Corp
NASDAQ:NVAC
|
US |
|
E
|
Ebet Inc
OTC:EBET
|
US |
|
Aksa Akrilik Kimya Sanayii AS
IST:AKSA.E
|
TR |
|
Z
|
Zijin Mining Group Co Ltd
F:FJZ
|
CN |
|
R
|
Ralco Corporation Bhd
KLSE:RALCO
|
MY |
|
L
|
Lightron Inc
KOSDAQ:069540
|
KR |
|
R
|
Rojana Industrial Park PCL
SET:ROJNA
|
TH |
|
M
|
Mercer Bancorp Inc
OTC:MSBB
|
US |
|
A
|
Altri SGPS SA
ELI:ALTR
|
PT |
Bankruptcy Probability
Innate Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innate Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Innate Pharma SA
PAR:IPH
|
159.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innate Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innate Pharma SA has total debt of 13.8m EUR. This includes both short-term (0 EUR) and long-term (13.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
